Skip to content

Clinical trials

Completed Bipolar Disorder trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Status: Completed Country / region: Germany Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20045
20052
20062
20072
20094
20101
20111
20141
20152
20161
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Charite University, Berlin, Germany2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Technische Universität Dresden2
Eli Lilly and Company1
Janssen Pharmaceutica N.V., Belgium1
Janssen Research & Development, LLC1
Johannes Gutenberg University Mainz1
Ludwig-Maximilians - University of Munich1
Max-Planck-Institute of Psychiatry1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder24
Schizophrenia5
Mania4
Depressive Disorder3
Psychotic Disorders3
Autistic Disorder1
Major Depressive Disorder1
Recurrence1
Schizophrenia, Paranoid1
Schizotypal Personality Disorder1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.